The Prostate Cancer Detection Rate on the Second Prostate Biopsy according to Prostate-Specific Antigen Trend
±èÇü»ó, ÀÌ⿵, Lim Dong-Hun, ±èö¼º, Baik Seung,
¼Ò¼Ó »ó¼¼Á¤º¸
±èÇü»ó ( Kim Hyung-Sang )
Chosun University School of Medicine Department of Urology
ÀÌ⿵ ( Lee Chang-Yong )
Chosun University School of Medicine Department of Urology
( Lim Dong-Hun )
Chosun University School of Medicine Department of Urology
±èö¼º ( Kim Chul-Sung )
Chosun University College of Medicine Department of Urology
( Baik Seung )
Chosun University College of Medicine Department of Urology
KMID : 0358320120530100686
Abstract
Purpose: To identify the prostate cancer detection rate on the patients who had second prostate biopsy out of the patients who were reported negative in their first biopsy.
Materials and Methods: From July 2006 to February 2012, prostate biopsy was performed on 843 patients with over 4 ng/ml and on 618 biopsy negative patients PSA was performed from between 6 months and 9 months after biopsy. On 164 patients, second biopsy was performed, and 42 patients were selected. If there was less than 10% change between PSA before the prostate biopsy and PSA measured during 6 to 9 months after the first biopsy it was considered as no change. If above 10% increase, it was considered increase and if above 10% decrease it was considered as decrease.
Results: The cancer detection rate in PSA increase group was 20%, the detection rate in no change in PSA level but still over the normal range group 8.3%, and that in the PSA decrease group was 0%. When comparing prostate cancer group and non-cancer group, it is more probable to have prostate cancer when they are older, prostate volume is smaller and PSA density is higher.
Conclusions: The second biopsy is strongly recommended when PSA level shows no change or increase, age is older, prostate volume is smaller or PSA density is higher.
Å°¿öµå
Biopsy; Prostate; Prostate-specific antigen; Prostatic neoplasms
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸